Jarushka Naidoo, MBBCh, is an assistant professor of oncology at the Sidney Kimmel Comprehensive Cancer Center and Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins University in Baltimore, MD.
She currently leads investigator-initiated trials for patients with lung cancer, specifically stage III non-small lung cancer and those with CNS metastases. She is a leader in the field of immune-related toxicity, having published the first comprehensive analyses of PD-1/PD-L1 pneumonitis, bullous, and inflammatory arthritis. She is recipient of several grants and awards including an NIH KL2 Clinical Scholar Award, American Society of Clinical Oncology (ASCO) Merit Award, PRIME Oncology Young Investigator Award for NSCLC, and a Young Immuno-Oncologist Award.
Dr. Naidoo graduated with her medical degree from Trinity College Dublin, completed both internal medicine training and a medical oncology fellowship through the Royal College of Physicians of Ireland, and completed an advanced fellowship at Memorial Sloan Kettering Cancer Center.
